Home
Conditions
Nervous System Neoplasms

Clinical trial condition

Nervous System Neoplasms

Explore clinical trials studying Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

2,889 public trials 686 recruiting studies

Refine in advanced search Browse all conditions

Nervous System Neoplasms trial results

Completed

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors

NCT03565367

Conditions: Central Nervous System Neoplasms, Malignant Central Nervous System Neoplasm, Metastatic Malignant Neoplasm in the Central Nervous System, +4 more
Locations: Stanford University School of Medicine Palo Alto, California, United States

View Trial Details

Completed

Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T

NCT02332902

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +15 more
Locations: The University of Texas Health Science Center at Houston Houston, Texas, United States

View Trial Details

Completed

Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

NCT02808650

Conditions: Central Nervous System Neoplasms, Childhood Solid Neoplasm, Neoplasms, +7 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital of Orange County Orange, California, United States

View all 21 locations

View Trial Details

Completed

A Study of RVT-1401 in Myasthenia Gravis (MG) Patients

NCT03863080

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations: IMC/Diagnostic and Medical Clinic Mobile, Alabama, United States

Phoenix Neurological Associates Phoenix, Arizona, United States

The Neurology Center of Southern California Carlsbad, California, United States

UC Irvine - MDA ALS and Neuromuscular Center Orange, California, United States

View all 20 locations

View Trial Details

Completed

Convection-Enhanced Delivery of 124I-Omburtamab for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy

NCT01502917

Conditions: Brain Cancer, Brain Diseases, Brain Neoplasms, +17 more
Locations: Weill Medical College of Cornell University New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

NCT04264143

Conditions: Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +17 more
Locations: Columbia University Irving Medical Center New York, United States

View Trial Details

Completed

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

NCT02684058

Conditions: Anaplastic Astrocytoma, Anaplastic Ganglioglioma, Anaplastic Oligodendroglioma, +37 more
Locations: Children's Hospital of Orange County Orange, California, United States

Childrens National Hospital Washington D.C., District of Columbia, United States

Nicklaus Childrens Hospital Miami, Florida, United States

Ann and Robert H Lurie Childrens Hospital of Chicago . Chicago, Illinois, United States

View all 57 locations

View Trial Details

Completed

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

NCT02312622

Conditions: Brain Diseases, Brain Neoplasms, Breast Diseases, +24 more
Locations: Stanford University, School of Medicine Stanford, California, United States

View Trial Details

Completed

Safety and Feasibility of the Infinity Catheter for Radial Access

NCT04553549

Conditions: Aneurysm, Arterial Occlusive Diseases, Arteriovenous Malformations, +33 more
Locations: University Hospital Newark, New Jersey, United States

View Trial Details

Completed

Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma

NCT02839720

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +29 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Nervous System Neoplasms

Nervous System Neoplasms trial results

Related conditions